<item>
  <date>2026-09-18</date>
  <hash>2dd8acd07409b5a7e3803d150d3b5747e1b2a7b9</hash>
  <images></images>
  <index>12</index>
  <keywords>
    <name>Committee for Medicinal Products for Human Use</name>
    <index>36</index>
    <slug>/wiki/committee%20for%20medicinal%20products%20for%20human%20use</slug>
  </keywords>
  <keywords>
    <name>European Medicines Agency</name>
    <index>13</index>
    <slug>/wiki/european%20medicines%20agency</slug>
  </keywords>
  <keywords>
    <name>Zealand Pharma</name>
    <index>1</index>
    <slug>/wiki/zealand%20pharma</slug>
  </keywords>
  <keywords>
    <name>short bowel syndrome</name>
    <index>70</index>
    <slug>/wiki/short%20bowel%20syndrome</slug>
  </keywords>
  <keywords_list>Committee for Medicinal Products for Human Use</keywords_list>
  <keywords_list>European Medicines Agency</keywords_list>
  <keywords_list>Zealand Pharma</keywords_list>
  <keywords_list>short bowel syndrome</keywords_list>
  <keywords_main>Zealand Pharma</keywords_main>
  <slug>/feed/2026/09/18/zealand-pharma-s-drug-zeydovio-receives-approval-by-the-european-medicines-agency-s-committee-for-medicinal-products-for</slug>
  <sources>
    <name>Reuters</name>
    <day>18</day>
    <hash>678c5f322656d8f8b178e7691cfe4b4f0510ba2d</hash>
    <month>9</month>
    <permalink>https://www.reuters.com/business/healthcare-pharmaceuticals/zealand-pharmas-short-bowel-syndrome-drug-wins-backing-eu-panel-2026-09-18/</permalink>
    <year>2026</year>
  </sources>
  <text>Zealand Pharma's drug Zeydovio receives approval by the European Medicines Agency's Committee for Medicinal Products for Human Use to treat short bowel syndrome. </text>
</item>
